These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 7065052)
1. Cardiovascular effects and progestins in oral contraceptives. Wynn V Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):718. PubMed ID: 7065052 [TBL] [Abstract][Full Text] [Related]
2. Contraceptive Steroids, age, and the cardiovascular system. Plunkett ER Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):747-51. PubMed ID: 7065055 [TBL] [Abstract][Full Text] [Related]
3. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data. Mann JI Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056 [TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Crook D; Godsland IF; Wynn V Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933 [TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
6. Risks and mechanisms of cardiovascular events in users of oral contraceptives. Meade TW Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1646-52. PubMed ID: 3287935 [TBL] [Abstract][Full Text] [Related]
7. Exogenous progestins and breast cancer. Stanford JL; Thomas DB Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216 [TBL] [Abstract][Full Text] [Related]
8. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference? Speroff L Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035 [TBL] [Abstract][Full Text] [Related]
9. Effects of progestogens on the cardiovascular system. Meade TW Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):776-80. PubMed ID: 6801983 [TBL] [Abstract][Full Text] [Related]
10. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220 [TBL] [Abstract][Full Text] [Related]
11. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
13. Effects of estrogens and progestogens on lipid metabolism. Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057 [TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives, blood clotting and thrombosis. Poller L Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338 [TBL] [Abstract][Full Text] [Related]
15. [Hormonal contraception]. Van Cauwenberge JR Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074 [TBL] [Abstract][Full Text] [Related]
16. Contraceptive choices in women with coagulation disorders. Comp PC; Zacur HA Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043 [TBL] [Abstract][Full Text] [Related]
20. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Gaspard UJ; Lefebvre PJ Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):334-43. PubMed ID: 2196805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]